CHANGING LIFESTYLES TO STOKE MORE GROWTH IN PHARMACEUTICALS
Total Reports: 459
Increase in demand for innovative drugs and therapies at affordable prices is a leading factor driving the pharmerging market value. Insurance companies located in pharmerging countries offer comprehensive policies to reduce the overheads of patients.
Rep Id : TMRGL8200 | Published | Pharmaceutical | April 2024
Increase in incidence of chronic diseases such as infectious diseases, autoimmune disorders, and cancer is a dominating factor contributing to the bioengineered protein drugs market growth.
Rep Id : TMRGL8188 | Published | Pharmaceutical | April 2024
Growth in prevalence of vision impairment is driving the ocular drug delivery technology market development. The most common ailments that need intraocular drug delivery systems include glaucoma, refractive errors, cataracts, dry eye syndrome, and Diabetic Macular Edema (DME).
Rep Id : TMRGL2869 | Published | Pharmaceutical | April 2024
Growth in incidence of chronic kidney diseases is fueling the chronic kidney disease (CKD) drugs market size. Commonly used CKD medicines include calcium acetate and calcium carbonate.
Rep Id : TMRGL2481 | Published | Pharmaceutical | April 2024
Rise in investment in regenerative medicine is fueling the specialty enzymes market size. Specialty enzymes play an important role in the field of regenerative medicine. They accelerate reactions and produce the desired target molecule in pharmaceuticals.
Rep Id : TMRGL2276 | Published | Pharmaceutical | April 2024
High prevalence of diabetes is fueling the diabetic neuropathy market development. Diabetic neuropathy affects people with diabetes. Pain management medications may be used to treat pain caused by diabetic neuropathy.
Rep Id : TMRGL2199 | Published | Pharmaceutical | April 2024
Increase in prevalence of chronic kidney diseases and cancer-related anemia is a key factor contributing to the erythropoietin drugs market growth. Impaired kidney is unable to release hormones vital for red blood cell production, thus resulting in the patient suffering from anemia that can be fatal if left untreated.
Rep Id : TMRGL1856 | Published | Pharmaceutical | April 2024
Rise in prevalence of rheumatoid arthritis is fueling the rheumatology therapeutics market size. Non-steroidal Anti-Inflammatory Agents (NSAIDs), corticosteroids, and Disease Modifying Anti-rheumatic Drugs (DMARDs) are widely employed in the treatment of rheumatic diseases and musculoskeletal disorders.
Rep Id : TMRGL1494 | Published | Pharmaceutical | April 2024
Rise in prevalence of rare diseases is one of the prominent factors augmenting the global orphan drugs market growth. Orphan pharmaceuticals are developed in order to treat rare ‘orphan’ diseases.
Rep Id : TMRGL1254 | Published | Pharmaceutical | April 2024
Increase in awareness regarding Alzheimer’s disease is a major factor driving the global Alzheimer's drugs market size. Alzheimer’s drugs or Alzheimer's therapies help slow down memory loss. They also help carry out routine activities.
Rep Id : TMRGL1245 | Published | Pharmaceutical | April 2024
Rise in incidence of autoimmune hair loss is one of the prominent platelet rich plasma and stem cell alopecia treatment market drivers. Platelet rich plasma (PRP) is recommended as a monotherapy or an adjuvant to hair transplantation.
Rep Id : TMRGL55800 | Published | Pharmaceutical | March 2024
Increase in incidence of gynecological disorders is driving the gynecology drugs market size. Gynecology drugs treat cancers of the reproductive system, cramping, pre-menstrual syndrome, and menstrual disorders such as menorrhagia.
Rep Id : TMRGL54756 | Published | Pharmaceutical | March 2024
Rise in cases of drug abuse is fueling the drugs of abuse testing market size. Urine testing is the most common test as it is non-invasive, quick, and able to qualitatively detect a wide range of drugs.
Rep Id : TMRGL85980 | Published | Pharmaceutical | March 2024
Viral clearance services are critical to the validation of downstream processes. They ensure the clearance of potential adventitious viruses in the event of contamination.
Rep Id : TMRGL53502 | Published | Pharmaceutical | March 2024
T-cell acute lymphoblastic leukemia (T-ALL), also known as T-cell immunophenotype, is one of the uncommon types of leukemia that can present with lymphomatous and/or leukemic manifestations.
Rep Id : TMRGL53283 | Published | Pharmaceutical | March 2024
Hepatitis is defined by inflammation of the liver, which is typically brought on by viral infections. The term "hepatitis therapeutics" describes various approaches to manage and treat the condition.
Rep Id : TMRGL52665 | Published | Pharmaceutical | March 2024
Immunoglobulins, also called immune globulins, are glycoproteins that are produced by protein-making cells participating in humoral immune responses against fungi, viruses, bacteria, cellular antigens, parasites, synthetic substances, and chemicals.
Rep Id : TMRGL52353 | Published | Pharmaceutical | March 2024
Membrane microfiltration is a filtration process that entails the usage of microporous media for retaining suspended solids of fluids. The pore size of the membrane ranges from 0.1 micron to 1 micron.
Rep Id : TMRGL51831 | Published | Pharmaceutical | March 2024
Targeted therapeutics, a type of cancer treatment, refers to the usage of drugs for targeting specific proteins and genes that help in the proliferation of cancer cells. These therapeutics can be used either solitarily or in combination with chemotherapy.
Rep Id : TMRGL51390 | Published | Pharmaceutical | March 2024
Sinusitis can be chronic, sub-acute, or acute, with various germs such as viruses and bacteria blocking the nasal cavities or filling them with fluid if left untreated. Furthermore, sinusitis can progress to complications such as meningitis or brain abscess if left untreated.
Rep Id : TMRGL50721 | Published | Pharmaceutical | March 2024
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
